ProQR Therapeutics (PRQR) Short-term Investments (2020 - 2026)
ProQR Therapeutics (PRQR) posted Short-term Investments of $18.5 million for Q2 2024, little changed sequentially from $18.5 million in Q1 2024.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Short-term Investments (2020 - 2026) Analysis & Trends
ProQR Therapeutics has reported Short-term Investments for 1 years, with the latest figure at $18.5 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | ProQR Therapeutics | 218.57 Mn | 82.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 247,583.07 |
| Mar 31, 2026 | 209,563.47 |
| Dec 31, 2025 | 272,386.18 |
| Sep 30, 2025 | 341,364.09 |
| Jun 30, 2025 | 328,268.31 |
| Mar 31, 2025 | 195,650.51 |
| Dec 31, 2024 | 500,102.65 |
| Sep 30, 2024 | 49,419.88 |
| Jun 30, 2024 | 198,147.31 |
| Mar 31, 2024 | 411,731.11 |
| Dec 31, 2023 | 334,617.31 |
| Sep 30, 2023 | 277,590.57 |
| Jun 30, 2023 | 405,079.87 |
| Mar 31, 2023 | 636,491.70 |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 145,191.50 |
| Jun 30, 2022 | 243,288.92 |
| Mar 31, 2022 | 313,132.22 |
| Dec 31, 2021 | 4.57 Mn |
| Sep 30, 2021 | 2.67 Mn |